Filtered By:
Source: Catheterization and Cardiovascular Interventions
Management: Food and Drug Administration (FDA)
This page shows you your search results in order of date.
Order by Relevance | Date
Total 1 results found since Jan 2013.
Percutaneous management of late leak after lariat transcatheter ligation of the left atrial appendage in patients with atrial fibrillation at high risk for stroke
ABSTRACT
Left atrial appendage (LAA) occlusion or ligation is a novel approach to stroke prevention in atrial fibrillation that may obviate the need for long‐term anticoagulation. The Lariat device has received Food and Drug Administration 510K clearance for the approximation of soft tissue and has been applied to transcatheter LAA ligation using a combined trans‐pericardial and transseptal approach. The occurrence of late leak after transcatheter LAA ligation and its percutaneous management has not been previously reported. Herein, we report three cases of late leak with reconstitution of the LAA after initially succe...
Source: Catheterization and Cardiovascular Interventions - October 15, 2013 Category: Cardiovascular & Thoracic Surgery Authors: William J. Mosley, Michael R. Smith, Matthew J. Price Tags: Case Report Source Type: research
